Eyewire News: The Podcast
11.18.26
Johnson & Johnson announces a major acquisition to expand its retinal diseases pipeline; CE Mark is granted for a retinal microcurrent stimulation device to treat dry AMD; and Newton’s Neurolens N3 eye-tracking measurement system is approved in Europe. Learn more about your ad choices. Visit megaphone.fm/adchoices
View full description +
Subscribe
Show More